You have honored me by electing me to be president of the Society for the past year and I thank you. It has been an exciting time with a new secretary/treasurer Jonathan Ravdin, a new editor McWilson Warren, a new program chair man Thomas Monath, and our first year under professional management. With all these changes, the year has gone well.
I was surprised, but pleased, to find that I was not alone in the anxiety of fashioning a presi dential address. Most past presidents have dis cussed their choice between a presentation on science or on issues of concern to our Society. In the past few years, many have tended to the lat ter. Although, initially, I was tempted to present a talk on science, and you can be assured that some of my younger colleagues urged me to do this, I believe it more in keeping with the needs of our Society and my role during the past year to do otherwise.
Having started to put a talk together, the anx iety got so acute that I did what I found almost all other speakers had done before me. I started reading other presidential addresses. I was amazed to find that I was actually sitting at the same desk in the library of the Marine Biological Laboratory in Woods Hole that Joe Cook had used while he did the same thing.' It was a beau tiful sunny day with a good wind. Looking out of the window at Eel Pond, I could see my new sailboat floating and beckoning like a siren to be taken into Nantucket Sound.
When I got down to work, it became clear that I wanted to talk about the logical outgrowth of the development of our Society and its problems.
Actually, we have evolved quite significantly in recent years. Past presidents had suggested that we get professional management, that there be changes in our journal and that we take a more active role in seeking government funding. All this has come to pass. We are not just standing still.
So I want to review with you what we have done, what we have learned, and what we need to do in the future to achieve one of our major goals: to obtain sufficient funds so that the spec trum of research and training covered by our Society from the most basic to the most applied can continue in a productive fashion.
One of our Council members warned me that many members were up to hereâ€"pointingto his forehead I assume, as he was on the phoneâ€"with the Legislative Task Force and suggested that my talk should be a potpourri of science, philosophy, and, above all, humor. Unfortunately, I am not the president of the Royal Society of Tropical Medicine and Hygiene, Professor George Nel son, who would have given you just that.2 (In cidentally, he was made an honorary member of our Society this year.) And so I will review the actions we have taken in our venture into the real world of politics and suggest where we should go from here.
Several In a letter from me as president-elect (this could not come from the president, who was a govern ment employee), our members were urged to write letters to their congressmen supporting these bills. They did so. This was our first taste of the leg islative process, and things began to move. However, the communications between the lobbyinggroup and ourselves were poor, and parts of the bills were written and changed without our approval. Because of this, we changed our pro fessional help and turned to Capitol Associates, directed by Terry Lierman, a man who had an excellent reputation for his work on Capitol Hill for the science community.
The liaison between Capitol Associates through Marguerite Donoghue and Anne Guthrie has been excellent. Their advice to change our strategy was reasonable. Authorization bills, like the one we had initiated, authorize that an action be taken. However, they do not provide money (although in the long run, they are meant to lead to appro priations bills, which do). And until new moneys are appropriated, everything that has been au thorized must come out of present funds. The bill in question also authorized a new regulatory body to oversee and direct research for tropical medicine in the various government agencies. We were advised that, based on past experience with such bureaucratic devices, less money would end up going for the actual research and training for which the bill had been designed.
The problems with authorization bills as com pared to appropriations bills were echoed when I met early this year with the administrators of the NIAID. They made it clear to me that if the authorization bill we were sponsoring in the House and Senate came to fruition without ap propriations (that is, without more money), funds for it would be taken from the present ROIs and other funds for tropical medicine. It was obvious to us that this should not happen, so we gingerly got our message through to the principals (and informed our membership), which was not easy and rather embarrassing, that we were withdraw ing our support for these authorization bills. We gave our reasons. I am told that our sponsors understood and that our cause has not suffered too much with them. At any rate, there has been no further action on these bills. But I am getting ahead of myself. The Legis lative Task Force Subcommittee met by confer ence call in early January this year to plan our priorities for 1990. First, of immediate impor tance, we agreed that we must do all we could to be sure that funds presently allocated for trop ical medicine in the USAID and Armed Forces programs were not cut but continued. Second, we focused on a long-term initiative to get more appropriations for tropical medicine research and training through the NIH. I asked that a repre sentative of our Society be invited to present testimony at the appropriate congressional hear ings this spring to promote these goals.
Our aim was not only to get the funds to in At the end of January, after my first visit to various congressmen and staff involved with the biomedical sciences, a visit guided by the expert help of Marguerite Donogliue and Anne Guthrie, it became clear that we could not just lobby for funds for ourselves in a narrow sense. If we were to achieve our goals, we had to help to increase, in general, the funding for biomedical research to the NIH and to other government agencies. The alternative of trying to get funds within an institute redistributed would not solve our prob lems. Indeed, many of us wear several hats and believe that it would not be justifiable, for in stance, to transfer funds from immunology or molecular biology or infectious diseases to trop ical medicine in the MAID. All these areas need more funds.
At this juncture, we learned that the Ad Hoc Group for Medical Research Funding, an orga nization made up of over 150 scientific societies and advocacy groups, was trying to increase the YR1991 budget to $9.24 billion for the NIH, a 19% increase over 1990 compared to the 4.7% increase requested in President Bush's budget. This amount would have restored the cuts made from downward negotiation, allowed for funding of approximately 35% of approved grants, in stead of around 17â€"25%, and substantially in creased funds for training and special projects.
Furthermore, Representative Barbara Boxer of California championed this increase in the NIH budget. The Council and Society members were urged to write letters supporting this in crease. I should add that, in a number of other instances, the Council and CPA were faxed and urged to write letters on relevant issues. I will propose methods to involve more of the mem bership in these endeavors in the future.
When I testified to the subcommittee for Health and Human Services and Labor for further funds, a plea was made for an increase in funds for tropical medicine and hygiene in particular and for the NIH in general, with arguments made for both. The disastrous state of the present funding situation was emphasized. I was struck by the testimony of others. The majority also made an effort to back the Ad Hoc proposal as well as their own particular issues. It appeared that some substantial increase in the budget for biomedical science would be made. An air of cautious op timism started to be felt. Robert Shope testified before the subcommittees responsible for trop ical research funded by the Defense Department in an effort to stem any cut that might come from across-the-board reductions in the defense bud get, and Sanford Kuvin testified before the sub committees overseeing the USAID budget to in sure that money directed to the malaria vaccine program continue.
More scientists came to Washington to solicit a bigger research budget for YR1991 than ever before.8 Chairman Natcher of the House Health and Human Services subcommittee commented that the witnesses this year were very compelling, maybe because an increased number of basic re searchers came to tell their story. When an as sistant professor of cell biology at Johns Hopkins reported how grants for non-AIDS research fell 27% at Hopkins between 1988â€"1990and that young researchers were virtually shut out, Natch er told her not to give up. Our voices seemed to be being heard.
But a problem arose in getting all the scientific groups behind a common cause. The need to pull together as as science community hit a serious snag. The American Society of Cell Biology and the American Society of Biochemistry and Mo lecular Biology sent a â€oeDear Colleagueâ€• letter to Congress in the spring, stating that all that was really needed was $200 million to support 1,000 new and competing ROIs. This recommendation left congressmen confused. Why should they have to spend $1.3 billion more for the NIH when respectable societies of scientists said that all that was needed was $200 million. It appeared that these two societies had totally blown it and un dercut the gigantic efforts of many, many groups to get increased funding across the board.
David Korn, Dean of Stanford University, commenting on this situation said that compet ing messages create the appearance that scientific societies care only for their own specific areas of interest. 8 When speaking to the staff of the Health and Human Services Subcommittee, I saw other ev idence of conflicting testimony that hurts our cause. One staff member told me that a Nobel laureate had assured him that there was really no funding problem because all good scientists get their grants funded. This is not true. It was made quite clear to me by administrators at the NIH that some excellent grants that had been approved last year were not funded because of budget limitations. I know personally of an ex cellent scientist whose NIH grant was turned down, only to receive a large Merit award in response to the repercussions of that decision. By then, it was too late; he was fed up and had gone into industry. In response to the setback caused by the disparate advice given to congress just described, Capitol Associates moved to con vince congressmen that the Ad Hoc Committee's proposal reflected much more closely the needs of the biomedical research community than that stated by the two societies. On April 19th, the House Budget Committee with the aid of Rep resentatives Barbara Boxer and Richard Durbin added an extra $750 million to the NIH budget. During the summer, the House and Senate Ap propriations Committees marked up the budget, a procedure which puts the finishing touches on what they want. After a compromise, they came up with a budget for the NIH of $8.5 billion, 12% over 1990.
We helped draft report language with Capitol Associates supporting tropical disease research and convinced the Congressional committee staff and Senator Harkin to insert it into the report of the Committee on Appropriations.
It summarized well the points in our testimony and read, The Committee has received a copy of the report prepared by the Institute (NIAID) on the subject of tropical medicine and infectious The Committee believes that it is impera tive to maintain expertise and revitalize re search efforts in this important area of re search. The Committee is particularly interested not only in ROI's but also in pro grams to strengthen centers in the United States and for training specialists with an overseas component to increase our capacity to deal with these diseases. Therefore, within the in crease provided to the Institute, the Commit tee requests that additional funds be directed to research in this crucial area and that a spending plan be submitted to the Committee within 90 days as to the amount of new funds to be provided out of the increase and the In stitute's plans in this high priority area.
At this point, we could not have asked for more. Our message had been heard.
Then came the notorious budget summit. We were asked to help to prevent one Senator from moving $68 million from the NIH budget to the homeless, and other attempts to divert funds from the NIH to a new but unfunded AIDS authori zation bill. Letters were sent out to the appro priate members of Congress on these issues.
At last, Congress passed the final budget, with an across-the-board cut of 2.41% of all programs in the Labor/HHS Appropriations bill, and ad journed. The analysis of the final bill, sent to me by Capitol Associates, shows that overall the NIH gets $8.3 17 billion, 9% more than 1990 (see Ta ble 1). NIAID gets $910 million, a 9.4% increase over 1990. This is a larger increase than several other institutes received, including the Cancer and Heart and Lung Institutes.
The CDC Infectious Disease Program received an 11.5% increase ($44.3 miffion) over 1990. We also had included, in the committee report, lan guage requesting analysis of their priorities.
A Foreign Operations Appropriations bill was passed after an 1ith hour compromise, on Sat urday, October 27th. This contained the lan guage we had developed in support the AID Ma laria Vaccine Research Program.
The Defense Appropriations bill stated that the Committee direct that the increase in $4,000,000 be used to support infectious disease research which is not classified as biologic de fense or AIDS research.
it is indeed fortunate that despite our present economic problems, the mega-deficit, and the Gulf crisis, we got the increases we did. Surely, it was worth the effort. We convinced the Con gress to insert language into the bill to direct that some of the increased funds for NIAID go for tropical medicine. Now we must work with NIAID to be sure that this language is translated into action.
To get all the funding we need will take time. We must not be discouraged because we were not completely successful on our first try. We are learning and will undoubtedly learn more as we continue. Most important, we have laid the groundwork for future efforts.
So what should we do? We need to increase our work on several fronts. First, we should persist in promoting our cause with the government, on Capitol Hill, the White House and the NIH. Related to this, we should join with others to seek funds for tropical med icine from sources other than Health and Human Services. Philip Russell, in his Presidential Ad dress in 1983, bemoaned the fact that we were not using the potential of medicine and public health as an effective tool to further our own national interests and to improve the quality of life in developing countries. The Department of State is a source of such funds. We should try to re-direct some of these funds into positive pro grams. I understand that the Institute of Medi cine now has a committee chaired by William Foege looking into the role of the U.S. Govern ment in international health. We hope this will lead to re-direction of funds to tropical medicine.
Second, we need to develop strategies to attract interest and support from the American people for biomedical science in general and our field in particular. Third, we should make sure we are in the arena to influence the major decisions made in government that determine the priorities for funding: i.e., how much money goes into health research and how much goes into other areas. Simply, this means we must be active citizens.
As far as the first effort aimed directly at leg islation, we should continue to work with Capitol Associates. They have proved to be an intelli gent, well-informed and active lobbying group for science. There has been a traditional belief held by some that scientists do not involve them selves with politicsâ€"even that science is separate from politics (anyone from Harvard is excepted, of course). As long as the mass of funds for bio medical science come from government, we must make the case for what we need. Senator Lowell Weicker, Jr., R. CT, a long-time champion of the biomedical sciences, has always encouraged individual scientists to get involved. â€oeYou've got to get your jerseys dirty. You're needed on the field of politics,â€•he says.
Indeed, we must reach more of the Congress. Moreover, our approach must be thoughtful and broad. I believe it is important to continue to join with other science groups lobbying for increases in funds in general. It is easier to put the point across and the voice is stronger and louder. And, in fact, when increased funds are appropriated, we will automatically get our share of ROIs at NIAID, as these are given on a com petitive basis. Similarly, the need to obtain funds for training and to improve the terrible state of old laboratory facilities and build new ones is a general problem, not just one for our Society. However, for special programs related to tropical medicine, including specifics in training, over seas activity, and core support, we must lobby not only Congress, but also the NIAID admin istration itself. This was told to me many times by the Congressional stalt Each of you should try and see your member of Congress when you come to Washington, DC. You may be surprised how pleased they and their staff are to see you. You should also invite them to visit your laboratories when they are at home in your district. I was intrigued to see how many were interested in biomedical science and thought it should have increased support. But, they have competing pressures, so we must increase our numbers, broaden our appeal and persist in pre senting our case.
In our Society, we should continue to expand the activities of the Legislative Task Force, the subcommittee of the Committee on Public AS fairs, which means that we must continue to fund this effort. We need to have better communi cation with the membership so that they can write to Congress on specific issues. We are start ing to develop a network with at least one co ordinator for each state. Then when important issues come to committees in Congress, our Leg islative Task Force could targetmembers, through the state coordinators, whose representatives are on key committees, to urge our case. We should also continue to use the News for these activities.
The second avenue takes a different path to making direct interactions with Congress more successful: that is, influencing Congress through a grass roots policy. This is a complicated and long-term task. But we do not need to start from scratch. For one thing, we should join actively with Research!Amenca, a new organization in Washington, DC whose president is Senator
Lowell Weicker, Jr. The stated goals of Re search!America are to gain public awareness of the benefits to humankind of medical research and to build a base of citizen support for more research into the cure, treatment and prevention of physical and mental disorders. This covers all of biomedical research. The powerful tone set by Senator Weicker, Jr., is sounded in one of his editorials published in the New York Times (1 February 1990). It starts, â€oeEvery American ought to be outraged about what is happening to one of our great public assetsâ€"the National Institutes of Health. The NIH is to medical research what NASA is to space exploration: uncontestedly the best in the world. Unfortunately, we're letting this great na tional resource run down badly.â€•It ends, â€oeThere is no better time and no more urgent cause for Americans to rally around than medical re search. There is no more deserving government enterprise than the NIH.
Research!America has been gathering infor She presented similar arguments and instructed her readers to write to Congress. it is difficult to imagine how one could get this message to more people. But, to be effective, the message must be sent over and over and over again.
Research!America is not promoting any par ticular disease or discipline, but uses current medical problems in the best ways it can to get the public's support. The Society has joined it and is listed as one of their sponsors in their literature. But now we need to interact with them in a more active manner. With them, we should develop editorials or TV spots using tropical in fectious diseases to illustrate the need for re search in general, as well as getting our particular research problems before the general public. I have discussed with the Council the need to have a subgroup of the CPA whose main mission is Recentpolls show that, of five research programs, Americanarank health research as the number one priority In allocating federal funds. Research to Improve weapons Is a dIstant fifth priority. In sharpcontrast to public opinion, the BushAdministrationgives top priority to researchto Improveweapons,based on its proposedFY91 R&D budget allocationsfor the samefive programs.
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Weapons Research experts were constrained by at their outset. This is an untenable proposition. I doubt that the pub lic would accept a reduction in biomedical re search at this time if they were consulted. Funds must be found in other areas that we feel have lower priority without carving up an area the majority of us believe to be of top priority. We have not heard the end of this report and I fear it will be used against us when we go to Congress again.
It is also interesting to see how President Bush's research and development budget priorities are out of step with public and Congressional opin ion (see Fig. 2@ ).
A recent story in the Boston Globe on October 25 by Fred Kaplan illustrates why we need to reorder our priorities. About the Hawk air de fense missiles that Iraq captured from Kuwait, Kaplan writes, â€oeAnalystshave commented in recent days on the irony and possible danger of American pilots facing American antiaircraft weapons.â€•â€oeThe issue,â€•several specialists said, â€oeis not whether the Iraqis can aim and fire, but whether they can maintain and repair the weap ons â€˜Theycouldn't possibly get them working,â€•said a former Pentagon air warfare specialist. â€oeEven the U.S. Army couldn't get them to work. We were lucky if they were working 20% of the time. There is no picture on the radar screen or there's no connection between the elec tronics and the missile. Without American ad visors and technicians, they can't get these things working. Period. Not a Chance. . . .â€oe â€oeJust sitting there, not even being used, the missile dies on you,â€•said a former missile testing officer. â€oeWe have 30% of the missiles sitting in storage just die. You get something that complex, with mil lions of possibilities to go wrong, it will go wrong.â€• Further, â€oeeven if a lot of Iraqi-held Hawks did work, most of them would not hit their tar gets.. . . if American pilots can maneuver, there's no danger,â€•and on and on and on. For years now, we've had a government that never saw a weapons system it didn't likeâ€"whether it works or not. Surely we can save money without en dangering our defense posture by not investing in weapons of mindboggling cost that don't work. Then there is the small budget item of defending Europe and Japan, our developed allies. Rep resentative Barney Frank recently said that the only reason we can possibly have for keeping our troops in Europe now is if we honestly believe that Bulgaria is about to invade France.
It is only by reordering our priorities as a na tion that we can develop and support research with the amount of money that will be necessary to renovate biomedical research facilities, pro vide appropriate training, and allow research sci entists to consider that this is a reasonable career in which you will be funded if you do good work. Unfortunately, the days of the quiet academic life in science are no longer with us. A fact of life is that we must fight for what we need. We need to find more members who are willing to do this, who, when they draw the short straw, will put energy and spirit into the task. If you want to go off on an expedition, whether you're off to dis cover the source of the Nile, like Burton and Speke, or to find the basis of drug resistance in parasites, you have to sell your scheme. Actually, when you get going, it's a lot of work, but it's also a lot of fun.
Thank you.
